Go to content
UR Home

SGLT2 Inhibitors and Their Mode of Action in Heart Failure—Has the Mystery Been Unravelled?

URN to cite this document:
urn:nbn:de:bvb:355-epub-493093
DOI to cite this document:
10.5283/epub.49309
Pabel, Steffen ; Hamdani, Nazha ; Luedde, Mark ; Sossalla, Samuel
[img]
Preview
License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)
Date of publication of this fulltext: 12 Oct 2021 05:18


Abstract

Purpose of review SGLT2 inhibitors (SGLT2i) are new drugs for patients with heart failure (HF) irrespective of diabetes. However, the mechanisms of SGLT2i in HF remain elusive. This article discusses the current clinical evidence for using SGLT2i in different types of heart failure and provides an overview about the possible underlying mechanisms. Recent findings Clinical and basic data ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons